Literature DB >> 3401092

Pernicious anemia. The expected findings of very low serum cobalamin levels, anemia, and macrocytosis are often lacking.

R Carmel1.   

Abstract

When patients are examined for possible cobalamin deficiency, great stress is often placed on the presence or absence of macrocytosis and anemia and on how low the serum cobalamin level is. The present study, however, shows that only 45 (64%) of 70 consecutively diagnosed patients with pernicious anemia, the most common cause of cobalamin deficiency, had very low cobalamin levels (less than 74 pmol/L [or less than 100 ng/L]). Anemia was absent in 13 (19%) of the patients, and macrocytosis was absent in 23 (33%) of the patients; such absence was particularly common when cobalamin levels were only slightly or moderately low (74 to 184 pmol/L). Coexisting iron deficiency was responsible for the absence of macrocytosis in nine patients. Of the ten patients with neither anemia nor macrocytosis, neurological disturbance was prominent in six, including four whose only noticeable abnormality was cerebral. These observations indicate that macrocytosis and anemia, two classic features of pernicious anemia, may be overstressed in our diagnostic approach. All subnormal serum cobalamin results are best viewed as pathological until proved otherwise. Emphasis on only very low cobalamin levels risks delaying the diagnosis of pernicious anemia in a substantial proportion of cases, particularly in those without anemia or macrocytosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3401092     DOI: 10.1001/archinte.148.8.1712

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  15 in total

1.  Nutritional vitamin B12 deficiency: two cases detected by routine newborn urinary screening.

Authors:  J L Michaud; B Lemieux; H Ogier; M A Lambert
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

Review 2.  Nutritional supplements in the ambulatory geriatric population. Should they be recommended?

Authors:  M L Freedman
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

3.  How I treat cobalamin (vitamin B12) deficiency.

Authors:  Ralph Carmel
Journal:  Blood       Date:  2008-07-07       Impact factor: 22.113

4.  Does the mean corpuscular volume help physicians evaluate hospitalized patients with anemia?

Authors:  S J Seward; C Safran; K I Marton; S H Robinson
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

5.  Relationship between vitamin B12 and sensory and motor peripheral nerve function in older adults.

Authors:  Kira Leishear; Robert M Boudreau; Stephanie A Studenski; Luigi Ferrucci; Caterina Rosano; Nathalie de Rekeneire; Denise K Houston; Stephen B Kritchevsky; Ann V Schwartz; Aaron I Vinik; Eva Hogervorst; Kristine Yaffe; Tamara B Harris; Anne B Newman; Elsa S Strotmeyer
Journal:  J Am Geriatr Soc       Date:  2012-06       Impact factor: 5.562

Review 6.  The role of B vitamins in preventing and treating cognitive impairment and decline.

Authors:  Martha Savaria Morris
Journal:  Adv Nutr       Date:  2012-11-01       Impact factor: 8.701

Review 7.  Pathophysiological effects of long-term acid suppression in man.

Authors:  R F McCloy; R Arnold; K D Bardhan; D Cattan; E Klinkenberg-Knol; P N Maton; R H Riddell; P Sipponen; A Walan
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

8.  Vitamin B12-induced reduction of platelet monoamine oxidase activity in patients with dementia and pernicious anaemia.

Authors:  B Regland; C G Gottfries; L Oreland
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 9.  Vitamin B12 and cognitive function: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2013-11-01

Review 10.  Subnormal vitamin B12 concentrations and anaemia in older people: a systematic review.

Authors:  Wendy P J den Elzen; Gerda M van der Weele; Jacobijn Gussekloo; Rudi G J Westendorp; Willem J J Assendelft
Journal:  BMC Geriatr       Date:  2010-06-23       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.